DIABETIC PERIPHERAL NEUROPATHY
Clinical trials for DIABETIC PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes drug combo soothe nerve pain?
Symptom relief OngoingThis study tests whether a new medicine called CagriSema can reduce painful nerve damage in people with type 2 diabetes. About 142 adults will receive either the active drug or a placebo for around 10 months. The main goal is to see if it lowers weekly pain scores.
Matched conditions: DIABETIC PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated May 26, 2026 07:27 UTC
-
Sugar check: can better glucose control predict nerve damage?
Knowledge-focused ENROLLING_BY_INVITATIONThis study measures how well nerves in the leg send signals in 50 adults aged 45-76 with diabetic peripheral neuropathy. Researchers will compare nerve speed with blood sugar levels, diabetes duration, and neuropathy screening scores. The goal is to find better ways to detect ner…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHY
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC